BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reeskamp LF, Tromp TR, Defesche JC, Grefhorst A, Stroes ESG, Hovingh GK, Zuurbier L. Next-generation sequencing to confirm clinical familial hypercholesterolemia. Eur J Prev Cardiol 2021;28:875-83. [PMID: 34298557 DOI: 10.1093/eurjpc/zwaa451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Tromp TR, Hovingh GK, Reeskamp LF. Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland". Arterioscler Thromb Vasc Biol 2022;42:e44-5. [PMID: 34936472 DOI: 10.1161/ATVBAHA.121.317188] [Reference Citation Analysis]
2 Halasz G, Piepoli MF. Focus on Atherosclerosis and Lipids. Eur J Prev Cardiol 2021;28:799-802. [PMID: 34057988 DOI: 10.1093/eurjpc/zwab090] [Reference Citation Analysis]
3 Hu H, Chen R, Hu Y, Wang J, Lin S, Chen X. The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia. Lipids Health Dis 2021;20:101. [PMID: 34511120 DOI: 10.1186/s12944-021-01536-3] [Reference Citation Analysis]
4 Hu H, Shu T, Ma J, Chen R, Wang J, Wang S, Lin S, Chen X. Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia. Front Genet 2021;12:762587. [PMID: 34970301 DOI: 10.3389/fgene.2021.762587] [Reference Citation Analysis]